Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesUse of drugs with anticholinergic effect and impact on cognition in Parkinson’s disease: A cohort study
Journal of Neurology, Neurosurgery, and Psychiatry , 10/08/09
Ehrt U et al. – The findings suggest that there is an association between the use of drugs with anticholinergic properties and cognitive decline in PD. This may provide an important opportunity for clinicians to avoid increasing progression of cognitive decline by avoiding such drugs if possible. Increased awareness by clinicians is required about the classes of drugs that have anticholinergic properties.
Today in Movement Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Paraplegia Following Image-Guided Transforaminal Lumbar Spine Epidural Steroid Injection: Two Case Reports
Pain Medicine, 10/29/09
Progression of Parkinson's disease in the clinical phase: potential markers
The Lancet Neurology, 11/12/09
A comparison of treatment thresholds in two large Parkinsons disease clinical trial cohorts
Movement Disorders, 11/17/09
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09
Escitalopram and Venlafaxine for the Prophylaxis of Migraine Headache Without Mood Disorders
Clinical Neuropharmacology, 10/02/09
Outcome of intracerebral haemorrhage patients pre-treated with statins
European Journal of Neurology, 11/17/09
Sponsor
Article Search
Sponsor